The mineralocorticoïd receptor (MR) and its ligand, aldosterone (aldo), are involved in cardiac diseases. Deleterious consequences of enhanced mineralocorticoid signaling has been highlighted by clinical trials showing a better survival amoung patients with heart failure treated with MR antagonists. Cardiomyocyte-MR regulated processes leading to these injuries are still unclear.
cardiovascular system appears early in the septic shock. The aim of this project was to determine the role of the endocardial endothelium (EE) in the cardiac β-adrenergic (β-AR) dysfunction at the early phase of septic shock.
Twelve weeks-old Sprague Dawley rats received either 5 mg.kg -1 of lipopolysaccharide (LPS) or saline (C) intravenously. 3h later, β-AR cardiac contractility was evaluated on papillary muscle with or without a functional EE. EE removal was performed with immersion in Triton X-100 at 0.5% during 3s and was validated by electronic microscopy and functional studies.
Surprisingly, isoproterenol (non-selective β-AR agonist) induced contractility was strongly increased in papillary muscle from LPS rat (+102±19% vs C; p<0.05). A similar increase was observed with a β 1 -AR stimulation (+90±25% vs C; p<0.05) whereas β 2 -AR and β 3 -AR produced similar contractility both in C and LPS muscles. The EE removal did not modifi ed β 1 -AR-induced contractility in C whereas it abolished the increased β 1 -AR response in LPS. In LPS papillary muscle, the increased β 1 -AR-induced contractility was not modifi ed by pretreatment with 1 μM L-NMMA, a NO synthase inhibitor, or 10 μM bosentan, an endothelin receptor antagonist. Conversely, the increased β 1 -AR-induced contractility was abolished by 10 μM indomethacin, a non selective cyclooxygenase (COX) inhibitor, as well as by selective inhibitors of COX1 (SC560, 3 μM) and COX2 (NS398, 3 μM).
Our results demonstrate the EE involvement in the increased cardiac β 1 -AR contractility at the early phase of endotoxemic shock. This effect is mediated through the activation of both COX1 and COX2 which appear as new putative therapeutic targets at the early phase of septic shock.
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People with heart failure (HF) are particularly sensitive to outdoor air quality as assessed by the increased risk of hospital cardiac readmission and mortality during peak pollution. Here, we explored the mechanisms underlying the increased cardiac sensitivity of HF patients following chronic exposure to carbon monoxide (CO), an ubiquitous environmental pollutant (second-hand smoke, vehicular exhaust, industrial emissions...).
Seven weeks after coronary artery ligation, rats were exposed to CO in an airtight exposure container for 4 weeks to reproduce air quality variations environmentally relevant.
We found that exposure of myocardial infarcted (MI) rats to CO exacerbated the MI-associated cardiac remodelling, resulting in increased occurrence of ventricular tachycardia and in vivo contractile dysfunction. The cellular origin for the aggravation of HF phenotype involved a remodeling of both Ca 2+ handling (Ca 2+ transient) and contractile machinery properties. The β-adrenergic reserve has been investigated both in vivo and in vitro. It was altered in MI animals, as expected, but was not worsened by chronic CO exposure.
In addition the altered mitochondrial metabolism and the pre-existent oxidative stress in MI rats were more pronounced after CO exposure. Acute antioxidant treatment with N-acetylcysteine reversed some of the MI-induced and CO-induced alterations at the cellular level, therefore suggesting potential benefi cial effects of antioxidant strategies. Moderate exercise training performed in standard fi ltered air attenuated cardiac remodelling and prevented the additional lesions induced by chronic CO exposure.
The present study shows that chronic exposure to low CO levels mimicking urban atmospheric pollution potentiates and worsens HF-associated cardiac remodelling, thus providing an explanation for epidemiological reports. Since oxidative stress is involved in the deleterious effects of CO pollution, antioxidant therapy or mild exercise could provide cellular protection against pollution effects.
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Endocardial endothelium dysfunction leads to an increased β1-adrenergic cardiac contractility through the cyclooxygenases pathway at the early endotoxemic shock David Roul (1), Benjamin Lauzier (1), Mortéza Erfanian (1), Damien Guijarro (1), Nolwenn Merlet (1), Bertrand Rozec (2), Chantal Gauthier (1) (1) Institut du thorax -Inserm UMR 1087 -CNRS UMR 6291, Nantes, France -(2) Institut du thorax, Nantes, France
The endothelial dysfunction plays an important role in the cardiovascular alterations during the septic shock. In addition the impaired sympathetic regulation of the Methods and Results: Balb/c nude mice underwent injection of tumor cells at D0. Nude mice without tumor injection served as control group. CCi mice lost weight overtime but no signifi cant difference of the heart/body weight ratio was observed between both groups. At D28, extensor digitorum longus (EDL) and hearts from both groups were collected to assess intracellular calcium (Ca 2+ ) imaging coupled with sarcomere length measurement. Studies were performed in basal condition or with β-adrenergic agonist, Isoproterenol (Iso). At the cellular level, EDL fi bers from CCi mice exhibited a signifi cant increase of spontaneous Ca 2+ sparks frequency compared to control mice, suggesting SR Ca 2+ release channels (ryanodine receptor 1, RyR1) remodeling. Freshly isolated CCi cardiomyocytes exerted an increase of Ca 2+ re-uptake (434±26 vs 559±37 ms, p<0.05), Ca 2+ transient amplitude and SR-Ca 2+ content (respectively 65%, p<0.05 and 68%) vs control cells. Moreover, diastolic Ca 2+ ratio was increased in CCi cells (0.67±0.005 vs 0.65±0.004; p<0.05). That is consistent with a signifi cant increase of Ca 2+ sparks occurrence revealing Ca 2+ leak through cardiac RyR2. Besides, CCi cells with Iso showed increased diastolic Ca 2+ waves (80% arrhythmic cells vs 20% in control cells). At the sarcomere level, CCi cells showed increased contraction amplitude (0.04±0.009 vs 0.014±0.003 μM, p<0.05).
Conclusion:
Cachexia induced modifi cations of Ca 2+ handling both in skeletal muscle and cardiac cells. It enhanced ECC, presumably to compensate muscle weakness and defective inotropy, which promoted arrhythmogenic susceptibility under adrenergic stimulation.
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Role of Neutrophil Gelatinase Associated Lipocalin (NGAL) in cardiovascular remodeling induced by aldosterone
Antoine Tarjus (1), Soumaya El Moghrabi (1), Céline Latouche (1), Patrick Rossignol (2), Faiez Zannad (2), Nicolette Farman (1), Natalia LóPez-Andrés (3) (1) Inserm U872 équipe 1, Paris, France -(2) Inserm U961 CIC Nancy, Nancy, France -(3) Centro de Investigacion Biomedica de Navarra, Pamplona, Espagne.
Background: Neutrophil Gelatinase Associated Lipocalin (NGAL) is a circulating protein, member of the lipocalin family, which binds MMP9 and modulates its stability and activity. We have recently shown that NGAL is a primary target of aldosterone/ mineralocorticoid receptor (MR) in endothelial cells, vascular smooth muscle cells and cardiomyocytes.
Objective: We hypothesized that NGAL could be a mediator of aldosterone/MR profi brotic and proinfl ammatory effects in the cardiovascular system.
Methods:
Wild type (WT) and NGAL Knock Out (KO) mice were subjected to an uni-nephrectomy aldosterone salt challenge (NAS, 200 μg/kg/day of aldo, 1% NaCl in tap water) for 4 weeks. Blood pressure (SBP) was measured by tail cuff method. Vascular reactivity was assessed by wire myograph. Cardiovascular fi brosis and infl ammation were analyzed by RT-PCR, western blot, immunohistochemistry and ELISA.
Results: There was no difference in SBP between transgenic mice compared to WT mice in basal condition. With NAS challenge, SBP was increased only in WT. Ex vivo aortic contraction induced by phenylephrine (Phe) and potassium chloride (KCl) were increased by NAS challenge in WT and KO. Responses to vasodilators (acetylcholine and sodium nitroprussiate) were altered in NAS condition in both groups. Quantifi cation of pro collagen I N-terminal peptide (PINP) in plasma showed an increase of PINP due to NAS treatment in WT that was prevented by NGAL inactivation. In myocardium, NAS treatment increased collagen type I and perivascular fi brosis in WT whereas KO were resistant to fi brosis. In aorta, collagen type I, vascular fi brosis and osteopontin were also increased by NAS in WT. These increases were prevented by NGAL inactivation.
Conclusion:
Our results show that NGAL plays a role in aldosterone/MR-mediated vascular fi brosis and infl ammation, but not in cardiac interstitial fi brosis and vascular dysfunction. We suggest that NGAL could be a new biotarget in cardiovascular fi brosis.
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Deletion of tenascin C decreases infl ammation and attenuates pressure overload induced cardiac dysfunction
Fanny Laroumanie (1), Christine Delage (2), Denis Calis (2), Joffrey Pozzo (1), Florence Tortosa (3), Dounia Abadi (1), Angelo Parini (1), Nathalie Pizzinat (1) (1) I2MC Inserm U1048, Remodelage cardiaque: aspects physiopathologiques et nouvelles thérapeutiques, Toulouse, France -(2) Inserm UMS006, Plateau de microchirurgie, Toulouse, France -(3) I2MC U1048, Signalisation cellulaire et remodelage cardiaque, Toulouse, France Introduction The extracellular matrix protein tenascin C (TnC) is highly expressed during embryogenesis. In adult tissues, TnC is not expressed under physiologic conditions but strongly induced in infl amed and remodeled tissues. Growing evidence linked TnC with development and complications of cardiovascular disease. We hypothesized that the absence of TnC would protect the heart from pressure overload induced cardiac dysfunction.
Methods: Transverse aortic constriction (TAC) or Sham operations were performed in male C57BL/6N wild type (WT) and TnC knockout (KO) mice. After 1 or 6 weeks, echocardiographic measurements of left ventricular (LV) parameters and standard methods for cardiac gene expression, collagen coloration and immunolocalization were employed.
Results:
In WT mice, TAC led to re-expression and protein deposition of TnC with a peak after 1 week (6.5% of heart surface vs 0% in Sham). Echocardiographic measurements after 6 weeks of TAC exhibited signifi cantly increased of ventricular hypertrophy in both WT+TAC and KO+TAC compared to Sham (LV posterior wall dimension WT+TAC:0.102±0.006 vs Sham: 0.078±0.003cm, p<0.01; KO+TAC:0.092±0.002 vs Sham:0.072±0.005 cm, p<0.5). However, cardiac dilation induced by TAC was observed in WT but not in KO (LV internal diastolic dimension; WT+TAC: 0.487±0.012 vs Sham: 0.375±0.009cm, p<0.001; KO+TAC 0.430±0.011 vs Sham 0.407±0.011). Myocardial contractility was also less reduced in KO+TAC than in WT+TAC (fractional shortening 23.4±1.5 vs 13.9±2 %, p<0.001). In parallel, collagen deposition was lower in KO+TAC than in WT+TAC. Strikingly, up regulation of infl ammatory cytokines genes induced by TAC in WT was completely abolished in KO. Heart deposition of TnC was clearly colocalized with area enriched in leukocyte cell marker and the deletion of TnC prevented macrophage recruitment induced by TAC.
Conclusion:
The absence of TnC attenuates the development of heart failure through possibly down regulation of infl ammatory response
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Alterations of calcium handling in cardiac and skeletal muscles in a model of cancer cachexia
Pierre Meschin (1), Véronique Garambois (2), Marion Pauly (1), Jérôme Roussel (3), Jean-Paul Vilaine (3), Nicole Villeneuve (3), Sylvain Richard (1), Alain Lacampagne (1) (1) Inserm, U1046, Montpellier, France -(2) Institut de recherche en cancérologie de Montpellier (IRCM), Montpellier, France -(3) Laboratoire de recherche Servier, Suresnes, France Aim: Cancer cachexia is associated with progressive loss of weight caused by malignant tumor growth leading to major impairment of muscular function (i.e. muscle weakness) due to atrophy. However, less is known about cardiac excitation-contraction coupling (ECC). Our objective was to evaluate ECC in a cancer-cachexia-induced (CCi) mouse model. Archives of Cardiovascular Diseases Supplements (2013), 5, 52-54 p<0.01), in the absence of changes in cardiac fi brosis (% collagen density ctrl 1.23±0.33, n=5; VS MCMR-/-1.40±0.31, n=4, ns).
Coronary endothelial dysfunction was assessed ex vivo testing the NO-mediated response to acetylcholine. In sham-operated animals, no difference between VS MCMR-/mice and littermate controls were observed (maximal relaxation ctrl 91±1, n=5; VS MCMR-/-83±2%, n=4, ns). CHF was associated with reduced response to Ach, indicating endothelial dysfunction, which was less severe in VS MCMR-/mice (ctrl 30±3, n=4; VS MCMR-/-54±2%, n=4, p<0.01].
Finally, coronary reserve was measured by MRI as the difference between basal and maximal LV perfusion obtained after stimulation by the A2a adenosinergic agonist ATL307. In sham-operated mice, MR deletion in VS MC resulted in a higher coronary reserve, (ctrl 3.4±0.9, n=4; VS MCMR-/-6.7±1.4 mL.mg-1.min-1, n=4, p=0.10). In CHF mice, VS MC MR defi ciency was associated with an increased basal coronary perfusion (ctrl 10.5±0.41; VS MCMR-/-12.0±0.5 mL.mg-1.min-1, p<0.05), probably responsible for the observed decrease in coronary reserve (ctrl 4.5±0.7, n=12; VS MCMR-/-1.5±0.6 mL.mg-1.min-1, n=9, p<0.01).
These results suggest that MR deletion in VS MC improves coronary endothelial function and cardiac perfusion, and this is associated with reduced cardiac dysfunction in this model of CHF.
Endothelial Protein Tyrosine Phosphatase 1B defi ciency reduces both endothelial and cardiac dysfunction in a mouse model of heart failure
Julie Maupoint, Najime Bouhzam, Elodie Gomez, Marie Besnier, Jean-Paul Henry, Paul Mulder, Vincent Richard Inserm U1096, Rouen, France Chronic heart failure (CHF) induces endothelial dysfunction, however the direct link between this dysfunction and aggravation of CHF is not demonstrated. We previously described a new treatment of CHF, based on inhibition of protein tyrosine phosphatase 1B (PTP1B), which both increases NO production (via restored PI3K/ Akt/eNOS signaling) and reduces adverse Left Ventricular (LV) remodeling and LV dysfunction. To address the direct link between endothelial protection and reduction of CHF, we evaluated in mouse CHF (left coronary ligation) the effects of endothelial PTP1B defi ciency (endoPTP1B-/-mice, obtained by crossing LOX-P PTP1B mice with mice expressing CRE under the control of the endothelial promoter Tie2).
Wild type (WT) CHF mice showed markedly impaired flow-mediated, NO-dependent dilatation of isolated mesenteric arteries (sham: 40±4%; CHF: 5±5; p<0.01), which was improved in endoPTP1B-/-mice (30±5%; p<0.01 vs WT CHF).
WT CHF mice had increased LV diameters and decreased LV fractional shortening (at 3 months: sham: 49±2; CHF: 12±1%; p<0.01), which were improved in endoPTP1B-/-mice (20±2%; p<0.01). LV pressure-volume curves showed that endoPTP1B-/-mice with CHF had reduced LV end-systolic (sham: 22.5±1.2%; CHF WT: 14.9±1.9%, p<0.05) and increased end-diastolic pressure-volume relationships (sham: 2.1±0.9%; CHF WT: 4.9±0.7%, p<0.05) demonstrating impaired systolic and diastolic dysfunction, respectively, which were both improved in endoPTP1B-/-mice (end-systolic: 20.6±2.3%, p>0.05; end-diastolic: 2.3±0.9%, p<0.05). Histological analysis showed cardiomyocyte hypertrophy and increased collagen density in WT CHF, which were reduced in endoPTP1B-/-mice, at identical infarct size.
Thus, endoPTP1B defi ciency not only induced an improvement of endothelial function, but also improved cardiac function and reduced adverse LV remodeling. These results provide a direct demonstration of the benefi cial effect of endothelial protection in the treatment of CHF.
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High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G MELAS mutation Karim Wahbi (1), Pascal Laforet (2), Edoardo Malfatti (2), Claude Jardel (2), Tanya Stojkovic (2), Anthony Behin (2), Bruno Eymard (2), Anne Lombès (3), Henri-Marc Bécane (2), Christophe Meune (1), Denis Duboc (1) (1) Hôpital Cochin, Paris, France -(2) Hôpital Pitié Salpêtrière, Paris, UMRS 975 hôpital Cochin, APHP, Paris, France Background: To determine the long-term incidence of cardiac life-threatening complications and death in patients with the m.3243A>G, and to identify cardiac prognostic factors.
